A line in the sand has been drawn by India's National Pharmaceutical Pricing Authority (NPPA) for 19 out of the top 100 drugmakers in the country to register on an online database by Friday. Failure to do so means the companies, which reportedly include IPCA Labs, IndSwift Laboratories and Dabur India, will need to "explain the reasons for not registering by making personal appearance before the Member Secretary." The database is to be used to set drug prices under formulas both domestic and multinational companies have criticized as overly intricate. Report